LMTK3
Basic information
Region (hg38): 19:48485271-48513935
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LMTK3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 75 | 76 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 0 | 0 | 76 | 6 | 4 |
Variants in LMTK3
This is a list of pathogenic ClinVar variants found in the LMTK3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-48491100-T-G | Benign (May 21, 2018) | |||
19-48491126-G-T | not specified | Uncertain significance (Jun 02, 2024) | ||
19-48491151-C-G | LMTK3-related disorder | Uncertain significance (May 17, 2024) | ||
19-48491194-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
19-48491222-C-G | not specified | Uncertain significance (Jul 14, 2023) | ||
19-48491234-C-G | not specified | Uncertain significance (Oct 12, 2021) | ||
19-48491421-C-A | not specified | Uncertain significance (May 29, 2024) | ||
19-48491478-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
19-48491505-G-C | not specified | Uncertain significance (Aug 12, 2021) | ||
19-48493827-G-T | not specified | Uncertain significance (Oct 02, 2023) | ||
19-48493897-C-T | not specified | Uncertain significance (Jun 18, 2024) | ||
19-48493906-G-C | not specified | Uncertain significance (Apr 07, 2023) | ||
19-48493921-C-T | not specified | Uncertain significance (Dec 14, 2022) | ||
19-48493922-GTCC-G | LMTK3-related disorder | Likely benign (Jun 21, 2023) | ||
19-48493945-C-T | not specified | Uncertain significance (Jul 19, 2023) | ||
19-48493953-C-T | not specified | Uncertain significance (Feb 14, 2023) | ||
19-48493977-G-T | not specified | Uncertain significance (Feb 22, 2023) | ||
19-48494005-C-G | not specified | Uncertain significance (Apr 07, 2023) | ||
19-48494008-C-A | not specified | Uncertain significance (Jul 14, 2022) | ||
19-48494043-G-A | not specified | Uncertain significance (Jan 02, 2024) | ||
19-48494059-A-G | not specified | Uncertain significance (Jun 12, 2023) | ||
19-48494106-C-T | not specified | Likely benign (Apr 07, 2023) | ||
19-48497413-C-T | not specified | Uncertain significance (Sep 26, 2022) | ||
19-48497456-G-C | not specified | Uncertain significance (Mar 20, 2024) | ||
19-48497464-C-T | not specified | Uncertain significance (Jan 31, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LMTK3 | protein_coding | protein_coding | ENST00000270238 | 16 | 27919 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000315 | 124579 | 0 | 2 | 124581 | 0.00000803 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.32 | 355 | 669 | 0.531 | 0.0000419 | 9231 |
Missense in Polyphen | 41 | 156.27 | 0.26237 | 1862 | ||
Synonymous | 1.91 | 276 | 319 | 0.864 | 0.0000228 | 3345 |
Loss of Function | 5.61 | 3 | 42.5 | 0.0706 | 0.00000213 | 559 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000181 | 0.0000177 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Protein kinase which phosphorylates ESR1 (in vitro) and protects it against proteasomal degradation. May also regulate ESR1 levels indirectly via a PKC-AKT-FOXO3 pathway where it decreases the activity of PKC and the phosphorylation of AKT, thereby increasing binding of transcriptional activator FOXO3 to the ESR1 promoter and increasing ESR1 transcription (PubMed:21602804). Involved in endocytic trafficking of N-methyl- D-aspartate receptors (NMDAR) in neurons (By similarity). {ECO:0000250|UniProtKB:Q5XJV6, ECO:0000269|PubMed:21602804}.;
Haploinsufficiency Scores
- pHI
- 0.160
- hipred
- hipred_score
- ghis
- 0.549
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.663
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lmtk3
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein phosphorylation;negative regulation of phosphatase activity
- Cellular component
- Golgi membrane;cellular_component;integral component of membrane;axon;dendrite
- Molecular function
- molecular_function;protein serine/threonine kinase activity;protein binding;ATP binding;metal ion binding